Market Research Logo

Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021

Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021

The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.

Based on end-users, the vaccines market is segmented into paediatrics and adults. The paediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.

Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.

The major factors contributing to the growth of the vaccines market include high prevalence of diseases, rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

The major players in this market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccines market. The report analyses the vaccines market by technology, type, disease indication, end-users, and regions
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccines market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccines market
Market Development: Comprehensive information about emerging markets. This report analyses the market for various vaccines across geographies
Market Diversification: Exhaustive information about new vaccines, untapped geographies, recent developments, and investments in the vaccines market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKET SEGMENTATION
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATION
    • MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • KEY DATA FROM SECONDARY SOURCES
    • KEY DATA FROM PRIMARY SOURCES
    • KEY INDUSTRY INSIGHTS
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • GLOBAL VACCINES MARKET
    • VACCINES MARKET, BY TYPE
    • GEOGRAPHIC ANALYSIS: VACCINES MARKET, BY END USER
    • GEOGRAPHIC ANALYSIS: VACCINES MARKET, BY TECHNOLOGY
    • GEOGRAPHICAL SNAPSHOT OF THE VACCINES MARKET
    • LIFECYCLE ANALYSIS, BY REGION, 2016
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCIDENCE OF DISEASES, 2014-2015
        • Table NIH FUNDING FOR VACCINE RESEARCH, 2012-2016 (USD MILLION)
        • Table HIGH PREVALENCE OF DISEASES TO BOOST THE VACCINES MARKET
      • RESTRAINTS
        • Table HUGE CAPITAL INVESTMENTS TO LIMIT THE MARKET GROWTH OF VACCINES
      • OPPORTUNITIES
        • Table HIGH GROWTH POTENTIAL IN EMERGING COUNTRIES TO BOOST THE MARKET FOR VACCINES
      • CHALLENGES
        • Table IMMUNIZATION COVERAGE, BY DISEASE, 2014
        • Table INADEQUATE ACCESS TO VACCINES A MAJOR CHALLENGE IN THE MARKET
      • BURNING ISSUES
    • INVESTMENT ANALYSIS
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
        • Table REGULATORY AUTHORITIES IN EUROPE
      • ASIA
        • Table REGULATORY AUTHORITIES IN ASIA
      • ROW
    • PATENT ANALYSIS
    • KEY PIPELINE PRODUCTS
      • Table KEY PIPELINE VACCINES
  • VACCINES MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
    • CONJUGATE VACCINES
      • Table CONJUGATE VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • INACTIVATED AND SUBUNIT VACCINES
      • Table EXAMPLES OF INACTIVATED AND SUBUNIT VACCINES
      • Table INACTIVATED AND SUBUNIT VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • LIVE ATTENUATED VACCINES
      • Table LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • TOXOID VACCINES
      • Table TOXOID VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • RECOMBINANT VACCINES
      • Table RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • VACCINES MARKET, BY TYPE
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
    • MONOVALENT VACCINES
      • Table MONOVALENT VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • MULTIVALENT VACCINES
      • Table EXAMPLES OF MULTIVALENT VACCINES
      • Table MULTIVALENT VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • VACCINES MARKET, BY DISEASE INDICATION
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD MILLION)
    • PNEUMOCOCCAL DISEASE
      • Table LIST OF PNEUMOCOCCAL VACCINES
      • Table VACCINES MARKET SIZE FOR PNEUMOCOCCAL DISEASE, BY REGION, 2014-2021 (USD MILLION)
    • DTP
      • Table LIST OF DTP VACCINES
      • Table VACCINES MARKET SIZE FOR DTP, BY REGION, 2014-2021 (USD MILLION)
    • INFLUENZA
      • Table LIST OF INFLUENZA VACCINES
      • Table VACCINES MARKET SIZE FOR INFLUENZA, BY REGION, 2014-2021 (USD MILLION)
    • HUMAN PAPILLOMA VIRUS
      • Table LIST OF HPV VACCINES
      • Table VACCINES MARKET FOR HPV, BY REGION, 2014-2021 (USD MILLION)
    • MENINGOCOCCAL DISEASE
      • Table LIST OF MENINGOCOCCAL VACCINES
      • Table VACCINES MARKET SIZE FOR MENINGOCOCCAL DISEASE, BY REGION, 2014-2021 (USD MILLION)
    • POLIO
      • Table LIST OF POLIO VACCINES
      • Table POLIO MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • ROTAVIRUS
      • Table LIST OF ROTAVIRUS VACCINES
      • Table VACCINES MARKET SIZE FOR ROTAVIRUS, BY REGION, 2014-2021 (USD MILLION)
    • HEPATITIS
      • Table LIST OF HEPATITIS VACCINES
      • Table VACCINES MARKET SIZE FOR HEPATITIS, BY REGION, 2014-2021 (USD MILLION)
    • MMR
      • Table LIST OF MMR VACCINES
      • Table VACCINES MARKET SIZE FOR MMR, BY REGION, 2014-2021 (USD MILLION)
    • VARICELLA
      • Table LIST OF VARICELLA VACCINES
      • Table VACCINES MARKET SIZE FOR VARICELLA, BY REGION, 2014-2021 (USD MILLION)
    • OTHERS
      • Table LIST OF OTHER VACCINES
      • Table VACCINES MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • VACCINES MARKET, BY END USER
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • PEDIATRICS
      • Table VACCINES MARKET SIZE FOR PEDIATRICS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR PEDIATRICS, BY COUNTRY, 2014-2021 (USD MILLION)
    • ADULTS
      • Table VACCINES MARKET SIZE FOR ADULTS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR ADULTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • VACCINES MARKET, BY REGION
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
        • Table U.S.: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
        • Table CANADA: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • U.K.
        • Table U.K.: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • FRANCE
        • Table FRANCE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • ITALY
        • Table ITALY: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • SPAIN
        • Table SPAIN: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
    • ASIA
      • Table ASIA: HEALTH EXPENDITURE PER CAPITA, BY COUNTRY, 2000 & 2014 (USD)
      • Table ASIA: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • JAPAN
        • Table JAPAN: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • CHINA
        • Table CHINA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • INDIA
        • Table INDIA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • REST OF ASIA (ROA)
        • Table ROA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2014-2021 (USD MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
      • REGULATORY APPROVALS
        • Table REGULATORY APPROVALS, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2013-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2013-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • GLAXOSMITHKLINE, PLC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • MERCK & CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • SANOFI PASTEUR
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
      • MNM VIEW
    • CSL LIMITED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
    • EMERGENT BIOSOLUTIONS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
    • MEDIMMUNE, LLC. (A SUBSIDIARY OF ASTRAZENECA)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2013-2016)
    • ASTELLAS PHARMA INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS, 2013-2016
    • SERUM INSTITUTE OF INDIA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report